|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,578.00 GBX | +0.85% |
|
+0.18% | -1.54% |
| 01:03am | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 01:03am | Race to launch weight-loss pill heats up as Novo wins UK approval | RE |
Insider Transaction History
Latest insider transactions for AstraZeneca PLC
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 20/05 | Sell | See Remarks | -11,893 | 185.78 | - | 0.0008% | ||
| 14/05 | Fiscal year | Chief Executive Officer | 18,359 | - | - | 0.0012% | ||
| 06/05 | Free | See Remarks | 1 | 186.28 | 186.28 | 0.0000% | ||
| 18/03 | Other | See Remarks | 34,375 | - | - | 0.0022% | ||
| 06/03 | Fiscal year | Chief Executive Officer | 14,967 | - | - | 0.0010% | ||
| 06/03 | Fiscal year | Chief Financial Officer | 4,863 | - | - | 0.0003% | ||
| 06/03 | Free | Chief Financial Officer | 42,393 | 152.42 | 6.46M | 0.0027% | ||
| 06/03 | Fiscal year | Chief Executive Officer | 101,495 | - | - | 0.0065% | ||
| 06/03 | Free | Chief Executive Officer | 103,581 | 152.42 | 15.79M | 0.0067% | ||
| 22/12 | Sell | Director | 297 | 134.96 | 40.08K | 0.0000% | ||
| 19/12 | Free | Director | 5,735 | - | - | 0.0004% | ||
| 19/12 | Don | Director | 5,735 | - | - | 0.0004% | ||
| 14/11 | Sell | Chief Financial Officer | 15,000 | 88.63 | 1.33M | 0.0010% | ||
| 10/11 | Don | Chief Executive Officer | 136,537 | - | - | 0.0088% | ||
| 25/09/25 | Buy | Director | 9 | 81.05 | 729.45 | 0.0000% | ||
| 18/08/25 | Sell | Chief Financial Officer | 9,563 | 115.12 | 1.1M | 0.0006% | ||
| 12/06/25 | Don | Chief Financial Officer | 200 | - | - | 0.0000% | ||
| 23/05/25 | Fiscal year | Chief Executive Officer | 8,970 | - | - | 0.0006% | ||
| 01/05/25 | Buy | Director | 1,400 | 71.66 | 100K | 0.0001% | ||
| 07/03/25 | Fiscal year | Chief Executive Officer | 89,962 | - | - | 0.0058% | ||
| 06/03/25 | Free | Chief Financial Officer | 28 | - | - | 0.0000% | ||
| 06/03/25 | Fiscal year | Chief Executive Officer | 17,357 | - | - | 0.0011% | ||
| 06/03/25 | Free | Chief Executive Officer | 248 | - | - | 0.0000% | ||
| 06/03/25 | Fiscal year | Chief Financial Officer | 2,021 | - | - | 0.0001% | ||
| 05/03/25 | Free | Chief Executive Officer | 124,404 | 119.63 | 14.88M | 0.0080% | ||
| 05/03/25 | Free | Chief Financial Officer | 51,737 | 119.63 | 6.19M | 0.0033% | ||
| 20/11/24 | Buy | Director | 3,000 | 63.40 | 190K | 0.0002% | ||
| 15/11/24 | Buy | Chairman | 2,000 | 100.30 | 201K | 0.0001% | ||
| 15/11/24 | Buy | Chief Executive Officer | 20,000 | 102.03 | 2.04M | 0.0013% | ||
| 13/11/24 | Buy | Director | 980 | 101.70 | 99.67K | 0.0001% | ||
| 13/09/24 | Buy | Chairman | 2,000 | 117.93 | 236K | 0.0001% | ||
| 12/06/24 | Don | Chief Executive Officer | 297,418 | - | - | 0.0192% | ||
| 15/05/24 | Free | Chief Executive Officer | 29,474 | 100.81 | 2.97M | 0.0019% | ||
| 12/03/24 | Fiscal year | Chief Executive Officer | 105,238 | - | - | 0.0068% | ||
| 06/03/24 | Free | Chief Financial Officer | 59,125 | 100.81 | 5.96M | 0.0038% | ||
| 06/03/24 | Free | Chief Executive Officer | 109,872 | 100.81 | 11.08M | 0.0071% | ||
| 06/03/24 | Fiscal year | Chief Executive Officer | 17,702 | - | - | 0.0011% | ||
| 22/02/24 | Free | Chief Executive Officer | 12,345 | - | - | 0.0008% | ||
| 14/12/23 | Buy | Director | 487 | 101.90 | 49.62K | 0.0000% | ||
| 23/11/23 | Buy | Chairman | 1,000 | 101.70 | 102K | 0.0001% | ||
| 23/11/23 | Buy | Chairman | 1,000 | 101.05 | 101K | 0.0001% | ||
| 09/05/23 | Sell | Chief Financial Officer | 19,470 | 74.81 | 1.46M | 0.0013% | ||
| 02/05/23 | Buy | Chairman | 2,000 | 117.01 | 234K | 0.0001% | ||
| 27/03/23 | Fiscal year | Chief Executive Officer | 138,093 | - | - | 0.0089% | ||
| 08/03/23 | Free | Chief Financial Officer | 45,449 | 108.21 | 4.92M | 0.0029% | ||
| 08/03/23 | Free | Chief Executive Officer | 100,256 | 108.21 | 10.85M | 0.0065% | ||
| 08/03/23 | Free | Chief Executive Officer | 8,853 | - | - | 0.0006% | ||
| 24/02/23 | Don | Chief Financial Officer | 200 | - | - | 0.0000% | ||
| 13/02/23 | Free | Chief Executive Officer | 15,187 | - | - | 0.0010% | ||
| 13/02/23 | Free | Chief Financial Officer | 7,514 | - | - | 0.0005% | ||
- Stock Market
- Stocks
- AZN Stock
- Company AstraZeneca PLC
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
















